Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-21-007637

EVP, General Counsel sold 54,659 shares at an average $63.99 ($3,497,902)

  • EVP, General Counsel acquired 109,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rivera Jose E · EVP, General Counsel

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +66,000 $6.83 $450,780 120,068 D
2021-02-01 Sale : show line 2 in the form −10,476 $63.31 $663,236 109,592 D
2021-02-01 Sale : show line 3 in the form −15,594 $64.11 $999,731 93,998 D
2021-02-01 Sale : show line 4 in the form −5,312 $65.01 $345,333 88,686 D
2021-02-01 Exercise or conversion : show line 5 in the form +33,000 $13.88 $458,040 121,686 D
2021-02-01 Sale : show line 6 in the form −6,617 $63.34 $419,121 115,069 D
2021-02-01 Sale : show line 7 in the form −8,366 $64.16 $536,763 106,703 D
2021-02-01 Sale : show line 8 in the form −2,827 $65.05 $183,896 103,876 D
Open-market sales · 54,659 sh · avg $63.99 · $3,497,902

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-02-01 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −66,000 39,117 D
2021-02-01 Exercise or conversion : show line 14 in the form Stock Option (right to buy) −33,000 72,000 D
2021-02-01 Exercise or conversion : show line 15 in the form Stock Option (right to buy) −10,000 61,000 D
Loading xslF345X03/doc4.xml…